The Europe Cell Viability Assays Market should witness market growth of 9.0% CAGR during the forecast period (2022-2028).
A commonly measured parameter in the cell viability assays is the integrity of the membrane. Cell-impermeant is membrane integrity dyes that can only enter live cells when there is a compromised plasma membrane. Usually, the membrane integrity viability dyes are made of Nucleic acid binding dyes and amine-reactive dyes.
A nucleic acid binding dye is nonfluorescent in aqueous media but shows increased fluorescence after joining with a double standard DNA or RNA. Propidium iodide (PI), SYTOX dead cell stains, and 7 amino actinomycin D (7 AAD) are some nucleic acid viability dyes. Amine reactive dyes bind covalently with the primary amine group available on the cellular proteins, which are present on the interior and exterior of the cells.
The signal is weak when the amine proteins are attached to the surface but showcases high signal intensity when the dye penetrates the cell with a compromised plasma membrane and reacts with the interior amine cellular protein. For flow cytometry, amine-reactive viability dyes contain live/dead fixable dead cell stains.
The German Federal Ministry of Education and Research (BMBF) published a medical information funding scheme on 16 November 2015 and a corresponding call for proposals, underlining the recognition of digitalization’s increasing role in healthcare and the potential to enhance treatment and diagnostics through the adoption of IT in medical research.
The Germany market dominated the Europe Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $160.4 million by 2028. The UK market is anticipated to grow at a CAGR of 8.1% during (2022-2028). Additionally, The France market would exhibit a CAGR of 9.9% during (2022-2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
A commonly measured parameter in the cell viability assays is the integrity of the membrane. Cell-impermeant is membrane integrity dyes that can only enter live cells when there is a compromised plasma membrane. Usually, the membrane integrity viability dyes are made of Nucleic acid binding dyes and amine-reactive dyes.
A nucleic acid binding dye is nonfluorescent in aqueous media but shows increased fluorescence after joining with a double standard DNA or RNA. Propidium iodide (PI), SYTOX dead cell stains, and 7 amino actinomycin D (7 AAD) are some nucleic acid viability dyes. Amine reactive dyes bind covalently with the primary amine group available on the cellular proteins, which are present on the interior and exterior of the cells.
The signal is weak when the amine proteins are attached to the surface but showcases high signal intensity when the dye penetrates the cell with a compromised plasma membrane and reacts with the interior amine cellular protein. For flow cytometry, amine-reactive viability dyes contain live/dead fixable dead cell stains.
The German Federal Ministry of Education and Research (BMBF) published a medical information funding scheme on 16 November 2015 and a corresponding call for proposals, underlining the recognition of digitalization’s increasing role in healthcare and the potential to enhance treatment and diagnostics through the adoption of IT in medical research.
The Germany market dominated the Europe Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $160.4 million by 2028. The UK market is anticipated to grow at a CAGR of 8.1% during (2022-2028). Additionally, The France market would exhibit a CAGR of 9.9% during (2022-2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
Scope of the Study
By Product
- Consumables
- Reagents & Assay Kits
- Luminometric Assays
- Dye Exclusion Assays
- Colorimetric Assays
- Fluorometric Assays
- Microplates
- Reagents & Assay Kits
- Instruments
- Spectrophotometer
- Microscopy
- Cell Imaging & Analysis System
- Flow Cytometry
- Others
By End-user
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutes
- Diagnostic Labs
By Application
- Stem Cell Research
- Drug Discovery & Development
- Diagnostics
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company
- PerkinElmer Inc.
- Promega Corporation
- Biotium
- Creative Bioarray
- Abcam Plc
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cell Viability Assays Market, by Product
1.4.2 Europe Cell Viability Assays Market, by End User
1.4.3 Europe Cell Viability Assays Market, by Application
1.4.4 Europe Cell Viability Assays Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Europe Cell Viability Assays Market by Product
4.1 Europe Consumables Market by Country
4.2 Europe Cell Viability Assays Market by Consumables Type
4.2.1 Europe Reagents & Assay Kits Market by Country
4.2.2 Europe Cell Viability Assays Market by Reagents & Assay Kits Type
4.2.2.1 Europe Luminometric Assays Market by Country
4.2.2.2 Europe Dye Exclusion Assays Market by Country
4.2.2.3 Europe Colorimetric Assays Market by Country
4.2.2.4 Europe Fluorometric Assays Market by Country
4.2.3 Europe Microplates Market by Country
4.3 Europe Instruments Market by Country
4.4 Europe Cell Viability Assays Market by Instruments Type
4.4.1 Europe Spectrophotometer Market by Country
4.4.2 Europe Microscopy Market by Country
4.4.3 Europe Cell Imaging & Analysis System Market by Country
4.4.4 Europe Flow Cytometry Market by Country
4.4.5 Europe Others Market by Country
Chapter 5. Europe Cell Viability Assays Market by End-user
5.1 Europe Biopharmaceutical & Pharmaceutical Companies Market by Country
5.2 Europe CROs & CMOs Market by Country
5.3 Europe Academic & Research Institutes Market by Country
5.4 Europe Diagnostic Labs Market by Country
Chapter 6. Europe Cell Viability Assays Market by Application
6.1 Europe Stem Cell Research Market by Country
6.2 Europe Drug Discovery & Development Market by Country
6.3 Europe Diagnostics Market by Country
Chapter 7. Europe Cell Viability Assays Market by Country
7.1 Germany Cell Viability Assays Market
7.1.1 Germany Cell Viability Assays Market by Product
7.1.1.1 Germany Cell Viability Assays Market by Consumables Type
7.1.1.1.1 Germany Cell Viability Assays Market by Reagents & Assay Kits Type
7.1.1.2 Germany Cell Viability Assays Market by Instruments Type
7.1.2 Germany Cell Viability Assays Market by End-user
7.1.3 Germany Cell Viability Assays Market by Application
7.2 UK Cell Viability Assays Market
7.2.1 UK Cell Viability Assays Market by Product
7.2.1.1 UK Cell Viability Assays Market by Consumables Type
7.2.1.1.1 UK Cell Viability Assays Market by Reagents & Assay Kits Type
7.2.1.2 UK Cell Viability Assays Market by Instruments Type
7.2.2 UK Cell Viability Assays Market by End-user
7.2.3 UK Cell Viability Assays Market by Application
7.3 France Cell Viability Assays Market
7.3.1 France Cell Viability Assays Market by Product
7.3.1.1 France Cell Viability Assays Market by Consumables Type
7.3.1.1.1 France Cell Viability Assays Market by Reagents & Assay Kits Type
7.3.1.2 France Cell Viability Assays Market by Instruments Type
7.3.3 France Cell Viability Assays Market by End-user
7.3.4 France Cell Viability Assays Market by Application
7.4 Russia Cell Viability Assays Market
7.4.1 Russia Cell Viability Assays Market by Product
7.4.1.1 Russia Cell Viability Assays Market by Consumables Type
7.4.1.1.1 Russia Cell Viability Assays Market by Reagents & Assay Kits Type
7.4.1.2 Russia Cell Viability Assays Market by Instruments Type
7.4.2 Russia Cell Viability Assays Market by End-user
7.4.3 Russia Cell Viability Assays Market by Application
7.5 Spain Cell Viability Assays Market
7.5.1 Spain Cell Viability Assays Market by Product
7.5.1.1 Spain Cell Viability Assays Market by Consumables Type
7.5.1.1.1 Spain Cell Viability Assays Market by Reagents & Assay Kits Type
7.5.1.2 Spain Cell Viability Assays Market by Instruments Type
7.5.2 Spain Cell Viability Assays Market by End-user
7.5.3 Spain Cell Viability Assays Market by Application
7.6 Italy Cell Viability Assays Market
7.6.1 Italy Cell Viability Assays Market by Product
7.6.1.1 Italy Cell Viability Assays Market by Consumables Type
7.6.1.1.1 Italy Cell Viability Assays Market by Reagents & Assay Kits Type
7.6.1.2 Italy Cell Viability Assays Market by Instruments Type
7.6.2 Italy Cell Viability Assays Market by End-user
7.6.3 Italy Cell Viability Assays Market by Application
7.7 Rest of Europe Cell Viability Assays Market
7.7.1 Rest of Europe Cell Viability Assays Market by Product
7.7.1.1 Rest of Europe Cell Viability Assays Market by Consumables Type
7.7.1.1.1 Rest of Europe Cell Viability Assays Market by Reagents & Assay Kits Type
7.7.1.2 Rest of Europe Cell Viability Assays Market by Instruments Type
7.7.2 Rest of Europe Cell Viability Assays Market by End-user
7.7.3 Rest of Europe Cell Viability Assays Market by Application
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Geographical Expansions:
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Bio-Rad laboratories, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.5 PerkinElmer, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 Merck KGaA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Abcam plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Promega Corporation
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Creative Bioarray
8.9.1 Company Overview
8.10. Biotium, Inc.
8.10.1 Company Overview
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company
- PerkinElmer Inc.
- Promega Corporation
- Biotium
- Creative Bioarray
- Abcam Plc
Methodology
LOADING...
